Filing Flows › Conmed (CNMD) › Free cash flow
Conmed (CNMD) free cash flow by quarter
Conmed's free cash flow was $46.7M in Q3 2026 (third quarter 2026), +37% from Q2 2026. Over the last 7 quarters it ranged from $10.6M (Q1 2026) to $48.5M (Q3 2025).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $46.7M | +37% | -4% |
| Q2 2026 | $34.2M | +223% | +46% |
| Q1 2026 | $10.6M | -74% | -72% |
| Q4 2025 | $41.2M | -15% | — |
| Q3 2025 | $48.5M | +107% | — |
| Q2 2025 | $23.4M | -38% | — |
| Q1 2025 | $37.8M | — | — |
Q3 2026 at a glance
Conmed, Q3 2026: revenue $336M (-0.7% year over year), operating margin 11.1%, net earnings $19.8M, operating cash flow $49.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is Conmed's free cash flow?
Conmed's free cash flow was $46.7M in Q3 2026 (third quarter 2026), +37% from Q2 2026.
How has Conmed's free cash flow changed?
Over the last 7 quarters it ranged from $10.6M (Q1 2026) to $48.5M (Q3 2025).